EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

P2RX7 plays a critical role in extracellular vesicle‐mediated secretion of pathogenic molecules from microglia and astrocytes

Mohammad Abdullah, Zhi Ruan, Seiko Ikezu, Tsuneya Ikezu iD

Journal of Extracellular Biology · 2024-07 · 3 (7)

DOI: 10.1002/jex2.155 ↗

At a glance

Journal article in Journal of Extracellular Biology, published online on 2024-06-27. Written by Mohammad Abdullah and 3 co-authors. Institution: Department of Neuroscience Mayo Clinic Florida Jacksonville Florida USA. Cited 11 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIA NIH HHS, National Institute on Aging, Cure Alzheimer's Fund.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Extracellular vesicle (EV) secretion is mediated by purinergic receptor P2X 7 (P2RX7), an ATP‐gated cation channel highly expressed in microglia. We have previously shown that administration of GSK1482160, a P2RX7 selective inhibitor, suppresses EV secretion from murine microglia and prevents tauopathy development, leading to the recovery of the hippocampal function in PS19 mice, expressing P301S tau mutant. It is yet unknown, however, whether the effect of GSK1482160 on EV secretion from glial cells is specifically regulated through P2RX7. Here we tested GSK1482160 on primary microglia and astrocytes isolated from C57BL/6 (WT) and P2rx7 –/– mice and evaluated their EV secretion and phagocytotic activity of aggregated human tau (hTau) under ATP stimulation. GSK1482160 treatment and deletion of P2rx7 significantly reduced secretion of small and large EVs in microglia and astrocytes in both ATP stimulated or unstimulated condition as determined by nanoparticle tracking analysis, CD9 ELISA and immunoblotting of Tsg101 and Flotilin 1 using isolated EVs. GSK1482160 treatment had no effect on EV secretion from P2rx7 –/– microglia while we observed significant reduction in the secretion of small EVs from P2rx7 –/– astrocytes, suggesting its specific targeting of P2RX7 in EV secretion except small EV secretion from astrocytes. Finally, deletion of P2rx7 suppressed IL‐1β secretion and phagocytosed misfolded tau from both microglia and astrocytes. Together, these findings show that GSK1482160 suppresses EV secretion from microglia and astrocytes in P2RX7‐dependment manner, and P2RX7 critically regulates secretion of IL‐1β and misfolded hTau, demonstrating as the viable target of suppressing EV‐mediated neuroinflammation and tau propagation.

Subjects

Author keywords

ATPCD9GSK1482160P2RX7Tsg101astrocytesextracellular vesicleflotillin‐1microglia

Authors and institutions

  • Department of Neuroscience Mayo Clinic Florida Jacksonville Florida USA.
  • Regenerative Science Graduate Program Mayo Clinic College of Medicine and Science Jacksonville Florida USA.

ORCID profiles: Tsuneya Ikezu

Funding

  • NIA NIH HHS
  • National Institute on Aging
  • Cure Alzheimer's Fund

Cite

APA

Abdullah, M., Ruan, Z., Ikezu, S., & Ikezu, T. (2024). P2RX7 plays a critical role in extracellular vesicle‐mediated secretion of pathogenic molecules from microglia and astrocytes. Journal of Extracellular Biology, 3(7). https://doi.org/10.1002/jex2.155

Vancouver

Abdullah M, Ruan Z, Ikezu S, Ikezu T. P2RX7 plays a critical role in extracellular vesicle‐mediated secretion of pathogenic molecules from microglia and astrocytes. Journal of Extracellular Biology. 2024;3(7). doi:10.1002/jex2.155

BibTeX
@article{Abdullah2024,
  author = {Abdullah, Mohammad and Ruan, Zhi and Ikezu, Seiko and Ikezu, Tsuneya},
  title = {P2RX7 plays a critical role in extracellular vesicle‐mediated secretion of pathogenic molecules from microglia and astrocytes},
  journal = {Journal of Extracellular Biology},
  year = {2024},
  volume = {3},
  number = {7},
  doi = {10.1002/jex2.155}
}
Start for free →